VolitionRx Ltd
VNRX
39 hedge funds and large institutions have $19.2M invested in VolitionRx Ltd in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 16 reducing their positions, and 9 closing their positions.
0.03% less ownership
Funds ownership: 0.61% → 0.58% (-0.03%)
10% less capital invested
Capital invested by funds: $21.3M → $19.2M (-$2.09M)
15% less funds holding
Funds holding: 46 → 39 (-7)
56% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 16
75% less call options, than puts
Call options by funds: $76K | Put options by funds: $306K
78% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LIM
Lagoda Investment Management
New York
|
+$999K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$60.4K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$49.2K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$40.2K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$27.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$671K |
| 2 |
Renaissance Technologies
New York
|
-$373K |
| 3 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
-$280K |
| 4 |
JP Morgan Chase
New York
|
-$118K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$118K |
VNRX Hedge Fund Activity: Q3 2021 in Review
39 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q3 2021, worth a combined $19.2M — down 9.8% from $21.3M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of VNRX and 2 opened new positions — a net loss of 7 holders — while 16 trimmed existing stakes and 7 added.
The largest buyer was Lagoda Investment Management, adding an estimated $999K. The largest seller was Millennium Management, cutting an estimated $671K.
- 39 institutional investors held VolitionRx Ltd (VNRX) as of Q3 2021, down from 46 in Q2 2021.
- Funds reported $19.2M of VolitionRx Ltd stock for Q3 2021, down 9.8% quarter-over-quarter.
- 2 funds opened new VolitionRx Ltd positions in Q3 2021 and 9 closed out, a net change of -7 holders.
- The largest VolitionRx Ltd buyer in Q3 2021 was Lagoda Investment Management, an estimated $999K added.
- The largest VolitionRx Ltd seller in Q3 2021 was Millennium Management, an estimated $671K sold.
Based on aggregated 13F filings for Q3 2021.